Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EV/Core EBITDA

    Back to All Ratios
SUN PHARMA ADVANCED RESEARCH COMPANY is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EV/Core EBITDA(x) 2.66-15.74-31.93-28.11

What is the latest EV/Core EBITDA ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EV/Core EBITDA ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is 2.66 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar20262.66
Mar2025-15.74
Mar2024-31.93
Mar2023-28.11

How is EV/Core EBITDA of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EV/Core EBITDA % Change
Mar2026 2.66
Positive
Mar2025 -15.74
Negative
Mar2024 -31.93
Negative
Mar2023 -28.11 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EV/Core EBITDA ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹6,788.5 Cr 6.6% 7.6% 42.2% Stock Analytics
PRIME FOCUS ₹24,488.5 Cr -10.8% 4.1% 73.1% Stock Analytics
SAGILITY ₹20,948.9 Cr -2.6% 1.5% -3.3% Stock Analytics
SYNGENE INTERNATIONAL ₹15,266.8 Cr -1.9% -8% -42.9% Stock Analytics
INDEGENE ₹14,688.1 Cr 2.3% 7% 1.2% Stock Analytics
INTERNATIONAL GEMOLOGICAL INSTITUTE ₹14,259.1 Cr 2% -5.3% -12.4% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

6.6%

7.6%

42.2%

SENSEX

-0.5%

-4.8%

-11%


You may also like the below Video Courses